Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.

Scarlett KA, White EZ, Coke CJ, Carter JR, Bryant LK, Hinton CV.

Mol Cancer Res. 2018 Apr;16(4):728-739. doi: 10.1158/1541-7786.MCR-16-0481. Epub 2018 Jan 12.

PMID:
29330286
2.

Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.

Coke CJ, Scarlett KA, Chetram MA, Jones KJ, Sandifer BJ, Davis AS, Marcus AI, Hinton CV.

J Biol Chem. 2016 May 6;291(19):9991-10005. doi: 10.1074/jbc.M115.712661. Epub 2016 Feb 3.

3.

ROS-mediated regulation of CXCR4 in cancer.

Chetram MA, Hinton CV.

Front Biol (Beijing). 2013 Jun 1;8(3). doi: 10.1007/s11515-012-1204-4.

4.

p62/SQSTM1 is required for cell survival of apoptosis-resistant bone metastatic prostate cancer cell lines.

Chang MA, Morgado M, Warren CR, Hinton CV, Farach-Carson MC, Delk NA.

Prostate. 2014 Feb;74(2):149-63. doi: 10.1002/pros.22737. Epub 2013 Sep 30.

5.

Cysteine (C)-X-C Receptor 4 Regulates NADPH Oxidase-2 During Oxidative Stress in Prostate Cancer Cells.

Jones KJ, Chetram MA, Bethea DA, Bryant LK, Odero-Marah V, Hinton CV.

Cancer Microenviron. 2013 Sep 28. [Epub ahead of print]

6.

Cysteine (C)-x-C receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cells.

Don-Salu-Hewage AS, Chan SY, McAndrews KM, Chetram MA, Dawson MR, Bethea DA, Hinton CV.

PLoS One. 2013;8(2):e57194. doi: 10.1371/journal.pone.0057194. Epub 2013 Feb 28.

7.

ROS-mediated activation of AKT induces apoptosis via pVHL in prostate cancer cells.

Chetram MA, Bethea DA, Odero-Marah VA, Don-Salu-Hewage AS, Jones KJ, Hinton CV.

Mol Cell Biochem. 2013 Apr;376(1-2):63-71. doi: 10.1007/s11010-012-1549-7. Epub 2013 Jan 12.

8.

PTEN regulation of ERK1/2 signaling in cancer.

Chetram MA, Hinton CV.

J Recept Signal Transduct Res. 2012 Aug;32(4):190-5. doi: 10.3109/10799893.2012.695798. Epub 2012 Jun 28. Review.

9.

ROS enhances CXCR4-mediated functions through inactivation of PTEN in prostate cancer cells.

Chetram MA, Don-Salu-Hewage AS, Hinton CV.

Biochem Biophys Res Commun. 2011 Jul 1;410(2):195-200. doi: 10.1016/j.bbrc.2011.05.074. Epub 2011 May 24.

10.

Loss of PTEN permits CXCR4-mediated tumorigenesis through ERK1/2 in prostate cancer cells.

Chetram MA, Odero-Marah V, Hinton CV.

Mol Cancer Res. 2011 Jan;9(1):90-102. doi: 10.1158/1541-7786.MCR-10-0235. Epub 2010 Nov 12.

11.

Role of the CXCR4/CXCL12 signaling axis in breast cancer metastasis to the brain.

Hinton CV, Avraham S, Avraham HK.

Clin Exp Metastasis. 2010 Feb;27(2):97-105. doi: 10.1007/s10585-008-9210-2. Epub 2008 Sep 24. Review.

PMID:
18814042
12.

Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis.

Hinton CV, Avraham S, Avraham HK.

J Cell Mol Med. 2008 Sep-Oct;12(5A):1517-26. doi: 10.1111/j.1582-4934.2008.00300.x. Epub 2008 Mar 19. Review.

13.

Phosphatidylinositol 3-kinase/Akt signaling enhances nuclear localization and transcriptional activity of BRCA1.

Hinton CV, Fitzgerald LD, Thompson ME.

Exp Cell Res. 2007 May 15;313(9):1735-44. Epub 2007 Mar 15.

Supplemental Content

Loading ...
Support Center